Epstein-Barr Virus-Associated Gastric Carcinoma and Specific Features of the Accompanying Immune Response - Wikidata - wikimedia - TriplyDB

Epstein-Barr Virus-Associated Gastric Carcinoma and Specific Features of the Accompanying Immune Response

Epstein-Barr Virus-Associated Gastric Carcinoma and Specific Features of the Accompanying Immune Response

http://www.wikidata.org/entity/Q26751029

about

Clinical utility of circulating cell-free Epstein-Barr virus DNA in patients with gastric cancer.Genomic pathobiology of gastric carcinoma.Clinical application of a cancer genomic profiling assay to guide precision medicine decisions.The oncogenic role of Epstein-Barr virus-encoded microRNAs in Epstein-Barr virus-associated gastric carcinoma.Strategies for Bispecific Single Chain Antibody in Cancer Immunotherapy.Immunoclassification characterized by CD8 and PD-L1 expression is associated with the clinical outcome of gastric cancer patients.A common molecular signature of intestinal-type gastric carcinoma indicates processes related to gastric carcinogenesis.Outlooks on Epstein-Barr virus associated gastric cancer.

P2860

Q33709895-ECA82BF2-DF9E-4DA1-B776-79DF51FEB1E1 Q38779428-B73DF591-E2E3-413D-BC24-9EF86CD96FDC Q40048521-215A6020-2FB1-4649-BB4B-2406A0C02F2A Q41921755-2BFB2E44-BB6E-45D0-8D99-7EC3C6A1FC67 Q47335259-FF68C93A-859C-48B9-A8B7-E893178F5127 Q52649601-4E6C851D-230F-434A-B59B-FA2BDF6980E8 Q52684153-18DDC9AE-9B94-4776-BEED-B4F6B73A7AAB Q52720624-ED51B772-EEA7-4570-99B5-E5AA702EED37

P2860

Epstein-Barr Virus-Associated Gastric Carcinoma and Specific Features of the Accompanying Immune Response

http://www.wikidata.org/entity/Q26751029

description

2016 nî lūn-bûn

@nan

2016 թուականի Մարտին հրատարակուած գիտական յօդուած

@hyw

2016 թվականի մարտին հրատարակված գիտական հոդված

@hy

2016年の論文

@ja

2016年論文

@yue

2016年論文

@zh-hant

2016年論文

@zh-hk

2016年論文

@zh-mo

2016年論文

@zh-tw

2016年论文

@wuu

name

Epstein-Barr Virus-Associated ...... e Accompanying Immune Response

@ast

Epstein-Barr Virus-Associated ...... e Accompanying Immune Response

@en

Epstein-Barr Virus-Associated ...... e Accompanying Immune Response

@nl

type

label

Epstein-Barr Virus-Associated ...... e Accompanying Immune Response

@ast

Epstein-Barr Virus-Associated ...... e Accompanying Immune Response

@en

Epstein-Barr Virus-Associated ...... e Accompanying Immune Response

@nl

prefLabel

Epstein-Barr Virus-Associated ...... e Accompanying Immune Response

@ast

Epstein-Barr Virus-Associated ...... e Accompanying Immune Response

@en

Epstein-Barr Virus-Associated ...... e Accompanying Immune Response

@nl

P1433

Q26751029-13938159-9EB8-4DF7-89D6-6DEF63C0762C

P1476

Q26751029-D5F79F45-D143-4E71-AE34-44DAFA70E02F

P2093

Q26751029-8018890A-3F34-494A-B6FD-19DBB1712514

Q26751029-8E0B3D63-FCF3-4FD0-8EC2-27A91F3A3F45

Q26751029-E1D14256-525E-4B24-94DB-3DEA0DD10A0A

P2860

Q26751029-0355AA04-1C4D-45B9-BE39-C4C70BC04837

Q26751029-0D03D327-1B7F-4CF7-B5D1-801F7756A778

Q26751029-12A06F7E-556F-468D-B902-B2409D790CD1

Q26751029-14D80A1A-D186-4DA7-A311-7CC7F08C6A69

Q26751029-1AB7365D-39F5-4165-98F0-968C1DE6A1CD

Q26751029-21D73903-EBE6-433B-AE9D-5698FF827EDD

Q26751029-2AAAA41E-AB47-4757-8496-4B46676605E4

Q26751029-2C824004-7E4B-444E-BC57-204C7F390758

Q26751029-2D31905D-5D58-4896-994D-506C666A96A2

Q26751029-3AC51E2F-23B4-48C7-845F-17BEAAFEB5D3

P304

Q26751029-F55274C9-232A-41E0-A181-CEC1D670CAFB

P31

Q26751029-102C172C-BF7F-40EF-91B1-EDFAB8D695FE

P3181

Q26751029-58DBD2E3-35D1-48A6-8714-273368785F4B

P356

Q26751029-C98BB089-3299-4AF6-9A77-70196536ED41

P407

Q26751029-0F86ACB9-F43D-4E99-B11B-F363178D5A8C

P433

Q26751029-E430E77E-6A2D-48F5-82DE-A8C0141E31E9

P478

Q26751029-BE893AA4-9208-4F70-9B79-E30E1A6B8BAF

P577

Q26751029-4376A3E4-DF9F-409F-8B1F-CB5CCAC772D6

P5875

Q26751029-ADFEBFD0-2A57-4B55-8FEF-089CECCC9B1F

P698

Q26751029-2CC1E943-41D6-47FE-96F4-AB1574F18BD1

P921

Q26751029-7A074CA3-B916-46C5-A760-49497C5F6124

Q26751029-C6231D3F-F0D3-497F-9140-A2E00D032CCF

P932

Q26751029-6780B4ED-A3A4-4E40-9F7F-44FBFA58111F

P3181

P356

JGC.2016.16.1.1

P1433

Journal of gastric cancer

P1476

Epstein-Barr Virus-Associated ...... e Accompanying Immune Response

@en

P2093

Junhun Cho

http://www.w3.org/2001/XMLSchema#string

Kyoung-Mee Kim

http://www.w3.org/2001/XMLSchema#string

Myung-Soo Kang

http://www.w3.org/2001/XMLSchema#string

P2860

Programmed cell death 1 ligand 1 and tumor-infiltrating CD8+ T lymphocytes are prognostic factors of human ovarian cancer

The immunoinhibitory B7-H1 molecule as a potential target in cancer: killing many birds with one stone

Comprehensive molecular characterization of gastric adenocarcinoma

Clinical significance of programmed death-1 ligand-1 and programmed death-1 ligand-2 expression in human esophageal cancer

Contribution of the PD-L1/PD-1 pathway to T-cell exhaustion: an update on implications for chronic infections and tumor evasion

Epstein-Barr virus: 40 years on

Colocalization of inflammatory response with B7-h1 expression in human melanocytic lesions supports an adaptive resistance mechanism of immune escape

Establishment and characterization of a human Epstein-Barr virus-associated gastric carcinoma in SCID mice

Correlation of Epstein-Barr virus and its encoded proteins with Helicobacter pylori and expression of c-met and c-myc in gastric carcinoma

VIRUS PARTICLES IN CULTURED LYMPHOBLASTS FROM BURKITT'S LYMPHOMA.

P304

1-7

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

4960194

http://www.w3.org/2001/XMLSchema#string

P356

10.5230/JGC.2016.16.1.1

http://www.w3.org/2001/XMLSchema#string

P407

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

16

http://www.w3.org/2001/XMLSchema#string

P577

2016-03-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

301487497

http://www.w3.org/2001/XMLSchema#string

P698

27104020

http://www.w3.org/2001/XMLSchema#string

P921

Epstein–Barr virus

P932

4834615

http://www.w3.org/2001/XMLSchema#string